<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37699157</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>09</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1477-0962</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>11</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Lupus</Title><ISOAbbreviation>Lupus</ISOAbbreviation></Journal><ArticleTitle>Risk factors of pulmonary arterial hypertension in patients with systemic lupus erythematosus: A meta-analysis.</ArticleTitle><Pagination><StartPage>1310</StartPage><EndPage>1319</EndPage><MedlinePgn>1310-1319</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/09612033231202398</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To determine the risk factors of pulmonary arterial hypertension (PAH) related to systemic lupus erythematosus (SLE) through systematic reviews and meta-analyses.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We undertook electronic search strategies using Medline via PubMed, Embase, Web of Science, and Cochrane Library up to April 11, 2023. Study selection and data extraction were performed by 2 authors independently. We made risk of bias judgments based on the Newcastle-Ottawa Scale (NOS). Pooled risk ratios (RRs) and 95% confidence intervals (CIs) were calculated to estimate the overall effect sizes of potential risk factors for PAH in SLE patients. Univariate and multivariate meta-regression models were used to assess the independent effects of each risk factor on PAH. Sensitivity analyses were also conducted to explore potential sources of heterogeneity.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 19 articles were included in this meta-analysis, and the results showed that gender (female) [RR = 1.04, 95% CI (1.02, 1.06), <i>p</i> = .0001], interstitial lung disease [RR = 4.36, 95% CI (2.42, 7.85), <i>p</i> = .0001], alopecia [RR = 1.39, 95% CI (1.06, 1.83), <i>p</i> = .017], Raynaud's phenomenon [RR = 1.83, 95% CI (1.41, 2.37), <i>p</i> = .0001], systemic hypertension [RR = 1.30, 95% CI (1.07, 1.58), <i>p</i> = .007], serositis [RR = 2.29, 95% CI (1.89, 2.77), <i>p</i> = .0001], pericardial effusion [RR = 3.33, 95% CI (2.20, 5.05), <i>p</i> = .0001], anti-RNP [RR = 1.86, 95% CI (1.19, 2.91), <i>p</i> = .006], anti-SSA [RR = 1.28, 95% CI (1.01, 1.62), <i>p</i> = .041], anti-SSB [RR = 1.38, 95% CI (1.19, 1.60), <i>p</i> = .0001], anti-U1RNP [RR = 1.58, 95% CI (1.07, 2.34), <i>p</i> = .023], thrombocytopenia [RR = 1.38, 95% CI (1.14, 1.68), <i>p</i> = .001], and current smokers [RR = 2.20, 95% CI (1.19, 4.06), <i>p</i> = .012] were all risk factors for PAH related to SLE.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">PAH is a serious complication of SLE. Since prognosis of SLE patients after the occurrence of PAH is poor, routine examination should be conducted for SLE patients with PAH risk factors.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yuqi</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0009-0008-0649-0414</Identifier><AffiliationInfo><Affiliation>Beijing Luhe Hospital, Capital Medical University, Beijing, China.</Affiliation><Identifier Source="RINGGOLD">12517</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Zhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Beijing Tiantan Hospital, Capital Medical University, Beijing, China.</Affiliation><Identifier Source="RINGGOLD">12517</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zha</LastName><ForeName>Bowen</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Beijing Anzhen Hospital, Capital Medical University, Beijing, China.</Affiliation><Identifier Source="RINGGOLD">12517</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xiaodong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Beijing Luhe Hospital, Capital Medical University, Beijing, China.</Affiliation><Identifier Source="RINGGOLD">12517</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gong</LastName><ForeName>Zhiyu</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Beijing Luhe Hospital, Capital Medical University, Beijing, China.</Affiliation><Identifier Source="RINGGOLD">12517</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>Lang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Central Laboratory, Beijing Luhe Clinical Institute, Capital Medical University, Beijing, China.</Affiliation><Identifier Source="RINGGOLD">12517</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Lingling</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-5270-9853</Identifier><AffiliationInfo><Affiliation>Beijing Key Laboratory of Diabetic Prevention and Research, Center for Endocrine Metabolism and Immune Diseases, Beijing Luhe Hospital, Capital Medical University, Beijing, China.</Affiliation><Identifier Source="RINGGOLD">12517</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lupus</MedlineTA><NlmUniqueID>9204265</NlmUniqueID><ISSNLinking>0961-2033</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000081029" MajorTopicYN="Y">Pulmonary Arterial Hypertension</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006976" MajorTopicYN="Y">Hypertension, Pulmonary</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Pulmonary arterial hypertension</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword></KeywordList><CoiStatement>Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>9</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>12</Day><Hour>18</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>12</Day><Hour>15</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37699157</ArticleId><ArticleId IdType="doi">10.1177/09612033231202398</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>